(197 days)
Not Found
Not Found
No
The provided 510(k) summary does not contain any explicit mentions of AI, ML, deep learning, or related terms, nor does it describe features or performance metrics typically associated with AI/ML-driven image analysis or interpretation.
No
The device is indicated for visualization purposes only, not for treating or alleviating a condition.
Yes
The device is used to "visualize cardiac structures and blood flow within the heart," which is a diagnostic function to assess the state of the heart.
No
The input imaging modality is an "Ultrasonic Pulsed Doppler Imaging System, Ultrasonic Pulsed Echo Imaging System," which are hardware devices. The summary does not explicitly state that the ViewMate System is solely software that processes data from these external hardware systems. Without a device description clarifying the system's components, it's not possible to confirm it's software-only.
Based on the provided information, the ViewMate System is not an IVD (In Vitro Diagnostic).
Here's why:
- Intended Use: The intended use is to "visualize cardiac structures and blood flow within the heart." This describes a device used in vivo (within the living body) for imaging and diagnosis, not a device used in vitro (outside the body) to examine samples like blood, urine, or tissue.
- Input Imaging Modality: The input modalities are "Ultrasonic Pulsed Doppler Imaging System" and "Ultrasonic Pulsed Echo Imaging System." These are imaging techniques used directly on the patient, not on biological samples.
- Anatomical Site: The anatomical site is "Cardiac structures," which are internal to the body.
IVD devices are specifically designed to perform tests on samples taken from the human body to provide information for diagnosis, monitoring, or screening. The ViewMate System's function is to acquire images directly from the patient's heart.
N/A
Intended Use / Indications for Use
The ViewMate System is indicated for use in adult and adolescent pediatric patients to visualize cardiac structures and blood flow within the heart.
Product codes (comma separated list FDA assigned to the subject device)
IYN, IYO, ITX
Device Description
Not Found
Mentions image processing
Not Found
Mentions AI, DNN, or ML
Not Found
Input Imaging Modality
Not Found
Anatomical Site
Cardiac, Intracardiac
Indicated Patient Age Range
adult and adolescent pediatric patients
Intended User / Care Setting
Not Found
Description of the training set, sample size, data source, and annotation protocol
Not Found
Description of the test set, sample size, data source, and annotation protocol
Not Found
Summary of Performance Studies (study type, sample size, AUC, MRMC, standalone performance, key results)
Not Found
Key Metrics (Sensitivity, Specificity, PPV, NPV, etc.)
Not Found
Predicate Device(s): If the device was cleared using the 510(k) pathway, identify the Predicate Device(s) K/DEN number used to claim substantial equivalence and list them here in a comma separated list exactly as they appear in the text. List the primary predicate first in the list.
Not Found
Reference Device(s): Identify the Reference Device(s) K/DEN number and list them here in a comma separated list exactly as they appear in the text.
Not Found
Predetermined Change Control Plan (PCCP) - All Relevant Information for the subject device only (e.g. presence / absence, what scope was granted / cleared under the PCCP, any restrictions, etc).
Not Found
§ 892.1550 Ultrasonic pulsed doppler imaging system.
(a)
Identification. An ultrasonic pulsed doppler imaging system is a device that combines the features of continuous wave doppler-effect technology with pulsed-echo effect technology and is intended to determine stationary body tissue characteristics, such as depth or location of tissue interfaces or dynamic tissue characteristics such as velocity of blood or tissue motion. This generic type of device may include signal analysis and display equipment, patient and equipment supports, component parts, and accessories.(b)
Classification. Class II.
0
Image /page/0/Picture/1 description: The image shows the logo for the U.S. Department of Health & Human Services. The logo features a stylized eagle or bird-like symbol with three curved lines representing its body and wings. The text "DEPARTMENT OF HEALTH & HUMAN SERVICES - USA" is arranged in a circular fashion around the bird symbol.
Food and Drug Administration 9200 Corporate Boulevard Rockville MD 20850
OCT 1 7 2003
EP MedSystems c/o Mr. John J. Talarico VP of QA/Regulatory Affairs Cooper Run Executive Park 575 Route 73 North, Building D West Berlin, NY 08091
Re: K031066
Trade Name: ViewMate® System Regulation Number: 21 CFR 892.1550, 892.1560, and 892.1570 Regulation Name: Ultrasonic Pulsed Doppler Imaging System Ultrasonic Pulsed Echo Imaging System Diagnostic Ultrasound Transducer Regulatory Class: Class II (two) Product Code: IYN, IYO, and ITX Dated: July 28, 2003 Received: July 29, 2003
Dear Mr. Talarico:
We have reviewed your Section 510(k) premarket notification of intent to market the device referenced above and we have determined the device is substantially equivalent (for the indications for use stated in the enclosure) to legally marketed predicate devices marketed in interstate commerce prior to May 28, 1976, the enactment date of the Medical Device Amendments, or to devices that have been reclassified in accordance with the provisions of the Federal Food. Drug, and Cosmetic Act (Act). You may, therefore, market the device, subject to the general controls provisions of the Act. The general controls provisions of the Act include requirements for annual registration, listing of devices, good manufacturing practice, labeling, and prohibitions against misbranding and adulteration.
This determination of substantial equivalence applies to the following transducers intended for use with the ViewMate® System, as described in your premarket notification:
Transducer Model Number VF-PA9F64E2D
If your device is classified (see above) into either class II (Special Controls) or class III (PMA), it may be subject to such additional controls. Existing major regulations affecting your device can be found in the Code of Federal Regulations, Title 21, Parts 800 to 898. In addition, FDA may publish further announcements concerning your device in the Federal Register.
1
Page 2 - Mr. John J. Talarico
Please be advised that FDA's issuance of a substantial equivalence determination does not mean that FDA has made a determination that your device complies with other requirements of the Act or any Federal statutes and regulations administered by other Federal agencies. You must comply with all the Act's requirements, including, but not limited to: registration and listing (21 CFR Part 807); labeling (21 CFR Part 801); good manufacturing practice requirements as set forth in the quality systems (OS) regulation (21 CFR Part 820); and if applicable, the electronic product radiation control provisions (Sections 531-542 of the Act): 21 CFR 1000-1050.
This determination of substantial equivalence is granted on the condition that prior to shipping the first device, you submit a postclearance special report. This report should contain complete information, including acoustic output measurements based on production line devices, requested in Appendix G. (enclosed) of the Center's September 30, 1997 "Information for Manufacturers Seeking Marketing Clearance of Diagnostic Ultrasound Systems and Transducers." If the special report is incomplete or contains unacceptable values (e.g., acoustic output greater than approved levels), then the 510(k) clearance may not apply to the production units which as a result may be considered adulterated or misbranded.
The special report should reference the manufacturer's 510(k) number. It should be clearly and prominently marked "ADD-TO-FILE" and should be submitted in duplicate to:
Food and Drug Administration Center for Devices and Radiological Health Document Mail Center (HFZ-401) 9200 Corporate Boulevard Rockville, Maryland 20850
This letter will allow you to begin marketing your device as described in your premarket notification. The FDA finding of substantial equivalence of your device to a legally marketed predicate device results in a classification for your device and thus permits your device to proceed to market.
If you desire specific advice for your device on our labeling regulation (21 CFR Part 801, please contact the Office of Compliance at (301) 594-4591. Additionally, for questions on the promotion and advertising of your device, please contact the Office of Compliance at (301) 594-4639. Also, please note the regulation entitled, "Misbranding by reference to premarket notification" (21 CFR Part 807.97). Other general information on your responsibilities under the Act may be obtained from the Division of Small Manufacturers, International and Consumer Assistance at its toll-free number (800) 638-2041 or at (301) 443-6597 or at its Internet address "http://www.fda.gov/cdrh/dsmamain.html".
2
Page 3 - Mr. John J. Talarico
If you have any questions regarding the content of this letter, please contact Sharon Lappalainen at (301) 443-8913.
Sincerely yours,
Megus Mayal
toy
Bram D. Zuckerman, M.D. Director Division of Cardiovascular Devices Office of Device Evaluation Center for Devices and Radiological Health
Enclosure
3
Diagnostic Ultrasound Indications for Use Form
ViewMate (Console) Ultrasound Imaging System (Model #VM-01)
Intended Use:
The ViewMate System is indicated for use in adult and adolescent pediatric patients to visualize cardiac structures and blood flow within the heart.
| Mode of Operation | ||||||||||
|---|---|---|---|---|---|---|---|---|---|---|
| Clinical Application | A | B | M | PWD | CWD | Color | ||||
| Doppler | Amplitude | |||||||||
| Doppler | Color | |||||||||
| Velocity | Combined | |||||||||
| (specify) | Other | |||||||||
| (Specify) | ||||||||||
| Ophthalmic | - | ー | - | l | ||||||
| Fetal | l | l | l | • | י | - | l | 1 | ||
| Abdominal | - | - | - | - | l | - | ||||
| Intraoperative (specify) | l | l | l | l | । | - | ||||
| Intraoperative Neurological | - | - | ー | - | 1 | |||||
| Pediatric | - | l | r | - | ||||||
| Small Organ (specify) | l | - | - | - | t | - | ﻪ | - | ||
| Neonatal Cephalic | - | l | - | - | ー | - | u | - | ||
| Adult Cephalic | l | - | - | - | 1 | - | - | |||
| Cardiac | - | - | - | - | - | - | - | - | ||
| Tranesphageal | l | l | ﺎ | - | l | ﮯ | ー | |||
| Transrectal | - | - | ||||||||
| Transvaginal | l | l | - | - | ー | - | - | |||
| Transurethral | l | - | ー | ﮯ | l | - | - | ﻪ | ||
| Intravascular | l | ー | l | - | - | - | י | - | ||
| Periphereral Vascular | - | l | t | l | l | - | - | * | ||
| Laparoscopic | l | l | l | - | • | - | - | - | 1 | |
| Musculo-skeletal Conventional | l | t | r | l | l | - | - | - | ||
| Musculo-skeletal Superfical | t | 1 | - | - | - | - | ﺖ | - | ﺳ | |
| Other- Intracardiac | - | N | N | N | - | ಗ |
N= new indication; P= previously cleared by FDA: E= added under Appendix E
Additional Comments:
(PLEASE DO NOT WRITE BELOW THIS LINE - CONTINUE ON ANOTHER PAGE IF NEEDED)
Concurrence of CDRH, Office of Device Evaluation (ODE)
Prescription Use (Per 21 CFR 801.109
C. Me Me May for BDZ
(Division Sign-Off)
Division of Cardiovascular Devices
File 3283a-ViewMate
510(k) Number K031066
4
Diagnostic Ultrasound Indications for Use Form
ViewFlex™ Ultrasound Catheter (Model # VF-PA9F64E2D)
The ViewMate System is indicated for use in adult and adolescent pediatric patients to Intended Use: visualize cardiac structures and blood flow within the heart.
| Mode of Operation | ||||||||||
|---|---|---|---|---|---|---|---|---|---|---|
| Clinical Application | A | B | M | PWD | CWD | Color | ||||
| Doppler | Amplitude | |||||||||
| Doppler | Color | |||||||||
| Velocity | Combined | |||||||||
| (specify) | Other | |||||||||
| (Specify) | ||||||||||
| Ophthalmic | - | - | - | - | - | - | - | - | - | - |
| Fetal | - | - | - | - | - | - | - | - | - | - |
| Abdominal | - | - | - | - | - | - | - | - | - | - |
| Intraoperative (specify) | - | - | - | - | - | - | - | - | - | - |
| Intraoperative Neurological | - | - | - | - | - | - | - | - | - | - |
| Pediatric | - | - | - | - | - | - | - | - | - | - |
| Small Organ (specify) | - | - | - | - | - | - | - | - | - | - |
| Neonatal Cephalic | - | - | - | - | - | - | - | - | - | - |
| Adult Cephalic | - | - | - | - | - | - | - | - | - | - |
| Cardiac | - | - | - | - | - | - | - | - | - | - |
| Tranesphageal | - | - | - | - | - | - | - | - | - | - |
| Transrectal | - | - | - | - | - | - | - | - | - | - |
| Transvaginal | - | - | - | - | - | - | - | - | - | - |
| Transurethral | - | - | - | - | - | - | - | - | - | - |
| Intravascular | - | - | - | - | - | - | - | - | - | - |
| Periphereral Vascular | - | - | - | - | - | - | - | - | - | - |
| Laparoscopic | - | - | - | - | - | - | - | - | - | - |
| Musculo-skeletal Conventional | - | - | - | - | - | - | - | - | - | - |
| Musculo-skeletal Superfical | - | - | - | - | - | - | - | - | - | - |
| Other- Intracardiac | - | N | N | N | - | N | - | - | - | - |
N= new indication; P= previously cleared by FDA: E= added under Appendix E
Additional Comments: ____________
(PLEASE DO NOT WRITE BELOW THIS LINE - CONTINUE ON ANOTHER PAGE IF NEEDED)
Concurrence of CDRH, Office of Device Evaluation (ODE)
Prescription Use (Per 21 CFR 801.109
Megan May for BOZ
(Division Sign-Off)
diovascular Devicesile 3283a-ViewFlexCatheter
510 k) N